PortfoliosLab logoPortfoliosLab logo
NKTR vs. CCEC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NKTR vs. CCEC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nektar Therapeutics (NKTR) and Capital Clean Energy Carriers Corp (CCEC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NKTR achieves a 38.51% return, which is significantly higher than CCEC's 13.04% return.


NKTR

1D
-8.30%
1M
-32.27%
YTD
38.51%
6M
6.76%
1Y
390.21%
3Y*
84.73%
5Y*
-26.23%
10Y*
-13.07%

CCEC

1D
-0.04%
1M
12.89%
YTD
13.04%
6M
15.08%
1Y
3.54%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

NKTR vs. CCEC - Yearly Performance Comparison


2026 (YTD)20252024
NKTR
Nektar Therapeutics
38.51%203.08%-31.62%
CCEC
Capital Clean Energy Carriers Corp
13.04%17.01%9.04%

Correlation

The correlation between NKTR and CCEC is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.02

Correlation (All Time)
Calculated using the full available price history since Aug 27, 2024

-0.03

Fundamentals

Market Cap

NKTR:

$1.45B

CCEC:

$1.37B

EPS

NKTR:

-$8.64

CCEC:

$4.01

PS Ratio

NKTR:

19.26

CCEC:

3.26

Total Revenue (TTM)

NKTR:

$55.63M

CCEC:

$418.16M

Gross Profit (TTM)

NKTR:

$44.58M

CCEC:

$240.75M

EBITDA (TTM)

NKTR:

-$121.05M

CCEC:

$338.22M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NKTR vs. CCEC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NKTR
NKTR Risk / Return Rank: 9595
Overall Rank
NKTR Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
NKTR Sortino Ratio Rank: 9898
Sortino Ratio Rank
NKTR Omega Ratio Rank: 9595
Omega Ratio Rank
NKTR Calmar Ratio Rank: 9797
Calmar Ratio Rank
NKTR Martin Ratio Rank: 9696
Martin Ratio Rank

CCEC
CCEC Risk / Return Rank: 4141
Overall Rank
CCEC Sharpe Ratio Rank: 4343
Sharpe Ratio Rank
CCEC Sortino Ratio Rank: 4040
Sortino Ratio Rank
CCEC Omega Ratio Rank: 3838
Omega Ratio Rank
CCEC Calmar Ratio Rank: 4242
Calmar Ratio Rank
CCEC Martin Ratio Rank: 4242
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NKTR vs. CCEC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nektar Therapeutics (NKTR) and Capital Clean Energy Carriers Corp (CCEC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NKTRCCECDifference

Sharpe ratio

Return per unit of total volatility

2.12

0.09

+2.03

Sortino ratio

Return per unit of downside risk

5.22

0.44

+4.79

Omega ratio

Gain probability vs. loss probability

1.59

1.05

+0.54

Calmar ratio

Return relative to maximum drawdown

9.43

0.11

+9.32

Martin ratio

Return relative to average drawdown

21.73

0.25

+21.48

NKTR vs. CCEC - Sharpe Ratio Comparison

The current NKTR Sharpe Ratio is 2.12, which is higher than the CCEC Sharpe Ratio of 0.09. The chart below compares the historical Sharpe Ratios of NKTR and CCEC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


NKTRCCECDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.12

0.09

+2.03

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.22

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.13

Sharpe Ratio (All Time)

Calculated using the full available price history

0.00

0.59

-0.58

Drawdowns

NKTR vs. CCEC - Drawdown Comparison

The maximum NKTR drawdown since its inception was -99.61%, which is greater than CCEC's maximum drawdown of -28.04%. Use the drawdown chart below to compare losses from any high point for NKTR and CCEC.


Loading charts...

Drawdown Indicators


NKTRCCECDifference

Max Drawdown

Largest peak-to-trough decline

-99.61%

-28.04%

-71.57%

Max Drawdown (1Y)

Largest decline over 1 year

-46.54%

-28.04%

-18.50%

Max Drawdown (3Y)

Largest decline over 3 years

-73.20%

Max Drawdown (5Y)

Largest decline over 5 years

-97.76%

Max Drawdown (10Y)

Largest decline over 10 years

-99.61%

Current Drawdown

Current decline from peak

-96.40%

-3.36%

-93.04%

Average Drawdown

Average peak-to-trough decline

-68.31%

-8.48%

-59.83%

Ulcer Index

Depth and duration of drawdowns from previous peaks

20.20%

12.61%

+7.59%

Volatility

NKTR vs. CCEC - Volatility Comparison

Nektar Therapeutics (NKTR) and Capital Clean Energy Carriers Corp (CCEC) have volatilities of 10.93% and 10.69%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NKTRCCECDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.93%

10.69%

+0.24%

Volatility (6M)

Calculated over the trailing 6-month period

64.10%

27.83%

+36.27%

Volatility (1Y)

Calculated over the trailing 1-year period

185.99%

41.02%

+144.97%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

121.81%

39.64%

+82.17%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

97.16%

39.64%

+57.52%

Dividends

NKTR vs. CCEC - Dividend Comparison

NKTR has not paid dividends to shareholders, while CCEC's dividend yield for the trailing twelve months is around 3.25%.


PositionTTM20252024
CCEC
Capital Clean Energy Carriers Corp
3.25%2.87%0.82%
NKTR
Nektar Therapeutics
0.00%0.00%0.00%

Financials

NKTR vs. CCEC - Financials Comparison

This section allows you to compare key financial metrics between Nektar Therapeutics and Capital Clean Energy Carriers Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00M40.00M60.00M80.00M100.00M20222023202420252026
10.86M
99.51M
(NKTR) Total Revenue
(CCEC) Total Revenue
Values in USD except per share items

Frequently Asked Questions


NKTR and CCEC have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NKTR has higher volatility (10.93%) compared to CCEC (10.69%). In terms of maximum drawdown, NKTR dropped -99.61% vs CCEC's -28.04%.

NKTR currently has the higher Sharpe Ratio (2.12 vs 0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NKTR and CCEC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer